Appendix Table 1.
Drug Group and Included Classes* |
Oral hypoglycemics |
Biguanides |
Sulfonylureas |
Nonsulfonylurea insulin secretagogues (Nateglinide, Repaglinide) |
α-Glucosidase inhibitors |
Thiazolidinediones |
DPP-4 inhibitors |
Long-acting insulin† |
NPH |
NPH–regular mix |
Aspart protamine/Aspart mix‡ |
Lispro protamine/Lispro mix‡ |
Detemir (Levemir)‡ |
Glargine (Lantus)‡ |
HMG-CoA reductase inhibitors (statins) |
All statins |
ACE inhibitors/ARBs |
All ACE inhibitors and ARBs |
ACE = angiotensin-converting enzyme; ARB = angiotensin-receptor blocker; DPP-4 = dipeptidyl peptidase-4; HMG-CoA = 3-hydroxy-3-methyl coenzyme A; NPH = neutral protamine Hagedorn.
Includes combination products for each drug group (e.g., glyburide–metformin).
Used for basal insulin coverage, either once or twice daily.
Insulin analogues.